Chaofu Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cardiac Fibrosis and Remodeling
Papers in
-
- RNA modifications and cancer 6
- Circular RNAs in diseases 4
- Cancer-related gene regulation 4
- Extracellular vesicles in disease 4
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
- Co-authors
- Bei Shi (18 shared papers)Junbo Ge (8 shared papers)Ranzun Zhao (11 shared papers)Changyin Shen (7 shared papers)Yongchao Zhao (9 shared papers)Weiwei Liu (9 shared papers)Yan Wang (7 shared papers)Fuhai Li (5 shared papers)
- Journals
- Life Sciences (4 papers)Theranostics (3 papers)Frontiers in Cardiovascular Medicine (2 papers)In Vitro Cellular & Developmental Biology - Animal (2 papers)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Chaofu Li
31 papers receiving 770 citations
Chaofu Li's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 238
- Cardiology and Cardiovascular Medicine 143
- Molecular Biology 471
- Immunology 54
- Pulmonary and Respiratory Medicine 65
Countries citing papers authored by Chaofu Li
This map shows the geographic impact of Chaofu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaofu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaofu Li more than expected).
Fields of papers citing papers by Chaofu Li
This network shows the impact of papers produced by Chaofu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaofu Li. The network helps show where Chaofu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaofu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets Hit paper breakdown → | 2023 | 143 |
| 2 | 2021 | 122 | |
| 3 | 2021 | 114 | |
| 4 | 2020 | 70 | |
| 5 | 2021 | 67 | |
| 6 | 2023 | 40 | |
| 7 | 2021 | 40 | |
| 8 | 2021 | 27 | |
| 9 | 2022 | 27 | |
| 10 | 2023 | 21 | |
| 11 | 2022 | 16 | |
| 12 | 2024 | 11 | |
| 13 | 2021 | 9 | |
| 14 | 2024 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2023 | 6 | |
| 20 | 2022 | 6 |
About Chaofu Li
Chaofu Li is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Immunology and Epidemiology, having authored 35 papers that have together received 775 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), Cancer-related gene regulation (4 papers), Extracellular vesicles in disease (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cancer Research (238 citations), Cardiology and Cardiovascular Medicine (143 citations), Molecular Biology (471 citations), Immunology (54 citations) and Pulmonary and Respiratory Medicine (65 citations). Chaofu Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Bei Shi, Junbo Ge, Ranzun Zhao, Changyin Shen, Yongchao Zhao, Weiwei Liu, Yan Wang, Fuhai Li, Weidong Xiong and Junbo Ge. Their work appears in journals such as Life Sciences, Theranostics, Frontiers in Cardiovascular Medicine, In Vitro Cellular & Developmental Biology - Animal and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.